Explore more publications!

The Boston Examiner: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Boston Examiner.

Press releases published on November 14, 2025

Houzeo's 'Share Listing' Feature Modernizes Massachusetts Home Discovery
Blakely Financial, Inc. Rebrands as ShorePoint Advisory Group
AI in Healthcare: Clinical Perspectives From the Frontlines
Houzeo Lists Massachusetts’ Safest Cities to Live for Homebuyers in 2025
Lumin Health Opens Fourth Site in Brookline, Expanding Evidence-Based Ketamine Therapy and Spravato
Sona Announces Long-Time Relationship with Medical Advisor, Dr. Tamara C. Takoudes, MD, FACOG
The Godfrey Hotel Boston: Setting the Standard in Guest Experience
CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Biogen Completes Acquisition of Alcyone Therapeutics
Global Commercial Real Estate Brand SVN® International PBC Appoints New Leasing Product Council Co-Chairs
ThumbPRO® Baseball Thumb Guard Used by Players in the 2025 World Series
SHAREHOLDER ALERT: Fiserv, Inc. Sued For Securities Fraud by Block & Leviton LLP; January 5 Deadline To Seek To Serve As Lead Plaintiff
Gordon Brothers Offering for Sale by Online Auction Dunstall Holdings Ltd. & Rea Valley Tractors Ltd. Plant & Equipment
Semiconductor Chip Market to Grow 16.1% Annually Despite Global Shortage
Vericel to Present at the Stephens Annual Investment Conference on Thursday, November 20, 2025
Cogent Biosciences Announces Participation in the Jefferies Global Healthcare Conference
Lifeward Ltd. Reports Third Quarter 2025 Financial Results
Sensei Biotherapeutics Reports Third Quarter 2025 Financial Results
Mersana Therapeutics Provides Business Update and Announces Third Quarter 2025 Financial Results
AMG Announces Conversion Rate Adjustment for its 5.15% Junior Convertible Trust Preferred Securities Due 2037

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions